JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 180 filers reported holding JUNO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.57 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $35,135,000 | +12.8% | 768,667 | +10.7% | 0.01% | +9.1% |
| Q3 2017 | $31,139,000 | +58.2% | 694,148 | +5.4% | 0.01% | +37.5% |
| Q2 2017 | $19,680,000 | +49.0% | 658,427 | +10.6% | 0.01% | +60.0% |
| Q1 2017 | $13,206,000 | +28.2% | 595,136 | +8.9% | 0.01% | 0.0% |
| Q4 2016 | $10,303,000 | -32.3% | 546,620 | +7.8% | 0.01% | -37.5% |
| Q3 2016 | $15,215,000 | -20.4% | 507,009 | +2.0% | 0.01% | -20.0% |
| Q2 2016 | $19,116,000 | +18.5% | 497,300 | +17.4% | 0.01% | +11.1% |
| Q1 2016 | $16,137,000 | -9.7% | 423,661 | +4.2% | 0.01% | -10.0% |
| Q4 2015 | $17,871,000 | +11.8% | 406,456 | +3.5% | 0.01% | 0.0% |
| Q3 2015 | $15,979,000 | +89.7% | 392,708 | +148.6% | 0.01% | +100.0% |
| Q2 2015 | $8,423,000 | -10.5% | 157,947 | +1.8% | 0.01% | 0.0% |
| Q1 2015 | $9,410,000 | +807.4% | 155,129 | +681.0% | 0.01% | +400.0% |
| Q4 2014 | $1,037,000 | – | 19,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|